Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium

Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures

(2018) Manel Essaidi-Laziosi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Establishment and characterization of an in vitro human small airway model (SmallAir™)

(2017) Song Huang et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

(2017) Simon D Harding et al.   NUCLEIC ACIDS RESEARCH

Animal models of respiratory syncytial virus infection

(2017) Geraldine Taylor   VACCINE

Activation Pathway of a Nucleoside Analog Inhibiting Respiratory Syncytial Virus Polymerase

(2016) Paul C. Jordan et al.   ACS Chemical Biology

Biochemical Effect of Resistance Mutations against Synergistic Inhibitors of RSV RNA Polymerase

(2016) Jerome Deval et al.   PLoS One

GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process

(2015) Michel Perron et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

(2015) Laurent Detalle et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Experimental design and analysis and their reporting: new guidance for publication in BJP

(2015) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study

(2015) Richard L. Mackman et al.   JOURNAL OF MEDICINAL CHEMISTRY

Use of qualitative integrative cycler PCR (qicPCR) to identify optimal therapeutic dosing time-points in a Respiratory Syncytial Virus Human Viral Challenge Model (hVCM)

(2015) Geraldine Kelly et al.   JOURNAL OF VIROLOGICAL METHODS

Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter

(2015) Sarah L. Noton et al.   JOURNAL OF VIROLOGY

Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge Study

(2015) John P. DeVincenzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate

(2015) Jerome Deval et al.   PLoS Pathogens

Characterization of a Respiratory Syncytial Virus L Protein Inhibitor

(2014) Choi-Lai Tiong-Yip et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study

(2014) John P. DeVincenzo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals

(2013) Bindiya Bagga et al.   ANTIVIRAL THERAPY

Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor

(2013) Hui Xiong et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Respiratory syncytial virus interaction with human airway epithelium

(2013) Remi Villenave et al.   TRENDS IN MICROBIOLOGY

In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo

(2012) R. Villenave et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection

(2012) Rachel J. Derscheid et al.   Viruses-Basel

Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus

(2010) John P. DeVincenzo et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET